Completed PHASE3 INTERVENTIONAL 2-arm NCT00440219

The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy.

Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Interventions Oral Prednisone Placebo comparator

Updated 6 times since 2017 Last updated: Jan 8, 2014 Started: Nov 30, 2010 Primary completion: Dec 31, 2012 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00440219, this PHASE3 trial focuses on Nasal Polyps and remains completed. Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Data source: Samuel Lunenfeld Research Institute, Mount Sinai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada